Shuttle Pharmaceuticals Holdings (SHPH) Debt Ratio (2021 - 2026)

Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Debt Ratio of 0.38 for Q1 2026, down 11.29% quarter-over-quarter from 0.42 in Q4 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Debt Ratio (2021 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Debt Ratio history runs 5 years deep, the most recent figure standing at 0.38 for Q1 2026.

In Q1 2026, Debt Ratio changed N/A year-over-year to 0.38; the TTM figure through Mar 2026 stood at 0.38 (changed N/A YoY), while the FY2025 annual figure was 0.42, changed N/A from the prior year.
Debt Ratio for Q1 2026 stood at 0.38, down from 0.42 in the prior quarter.
The five-year high for Debt Ratio was 0.42 in Q4 2025, with the low at 0.01 in Q3 2022.
The 4-year median for Debt Ratio is 0.01 (2023), against an average of 0.17.
Peak annual rise in Debt Ratio reached 92.47% in 2022, while the deepest fall reached 92.47% in 2022.
Shuttle Pharmaceuticals Holdings' Debt Ratio stood at 0.01 in 2022, then soared by 58.13% to 0.01 in 2023, then soared by 3074.06% to 0.42 in 2025, then slipped by 11.29% to 0.38 in 2026.
Business Quant data shows SHPH's Debt Ratio at 0.38 in Q1 2026, 0.42 in Q4 2025, and 0.01 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	-0.13
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn	0.42
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	0.32
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	0.12
10	Shuttle Pharmaceuticals Holdings	1.91 Mn	1.91 Mn	-	0.38

Download Data